Subscribe to Newsletter

Content by Rob Coker:

Discovery & Development Clinical Trials

Digitally Decentralized by Design

| Rob Coker | 3 min read

Through a partnership with software developer Medable, Syneos Health aims to decentralize and personalize clinical trials.

Discovery & Development Clinical Trials

The World’s Most Studied Disease

| Rob Coker | 5 min read

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

Discovery & Development Drug Discovery

Memorable Mushrooms

| Rob Coker | 2 min read

These fungi have some real nerve (developing properties).

Business & Regulation Digital Technologies

Video: Matthew Lakelin on Improving Supply Chain Efficiency

| Rob Coker

A video interview covering supply chain improvement technology

Manufacture Advanced Medicine

A New Era in Healthcare

| Rob Coker | 3 min read

What are the societal impacts of rapid advances in the life science sector?

Discovery & Development Drug Discovery

The Changing of The Season

| Rob Coker | 3 min read

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza

Discovery & Development Drug Discovery

Flu Season: March of the mAbs

| Rob Coker | 3 min read

As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments

Discovery & Development Drug Discovery

Getting Creative with Rare Diseases

| Rob Coker | 9 min read

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments

Discovery & Development Drug Discovery

The Blood Clot and the Invisible Frog

| Rob Coker | 2 min read

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

Discovery & Development Drug Discovery

Close the Care Gap

| Rob Coker | 9 min read

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register